Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 6/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.38 |
| ▸ | CCR1 | P32246 | 1/20 | 0.38 |
| ▸ | CCR8 | P51685 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23296360 | 0.91 | CYP2A6 (0.40) | TGFBR1IRAK4CYP2A6SQORCYP11B2 | |
| SCHEMBL23296368 | 0.89 | TGFBR1 (0.39) | TGFBR1IRAK4CYP2A6SQORCYP11B2 | |
| SCHEMBL22562198 | 0.88 | TGFBR1 (0.37) | TGFBR1IRAK4ALDH1A1KDM4EHPGD | |
| SCHEMBL22562384 | 0.88 | ADORA2A (0.39) | TGFBR1ALDH1A1HSD17B10 | |
| SCHEMBL23296293 | 0.88 | IRAK4 (0.37) | TGFBR1IRAK4CCR1CCR8CYP2A6 | |
| SCHEMBL22562386 | 0.87 | TGFBR1 (0.47) | TGFBR1IRAK4ALDH1A1KDM4EHPGD | |
| SCHEMBL22562194 | 0.87 | TGFBR1 (0.34) | TGFBR1IRAK4ALDH1A1KDM4EHPGD | |
| SCHEMBL23296383 | 0.87 | TGFBR1 (0.40) | TGFBR1IRAK4ALDH1A1KDM4EHPGD | |
| SCHEMBL23296423 | 0.87 | KMT2A (0.43) | ALDH1A1KDM4EHPGDSQORL3MBTL1 | |
| SCHEMBL31273346 | 0.87 | KMT2A (0.43) | ALDH1A1KDM4EHPGDSQORL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX INC (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2025-07-22 | — | — | US | disclosed |
| EP-4498784-A2 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | Kyulux, Inc. (JP) | 2025-01-29 | — | — | EP | disclosed |
| EP-3775100-B1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX INC (JP) | 2025-01-22 | — | — | EP | disclosed |
| US-20210135119-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2021-05-06 | — | — | US | disclosed |
| US-20210135119-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210135119-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | TGFBR1 4281/4885IRAK4 4111/4885CCR1 3762/4885 |
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | TGFBR1 4281/4885IRAK4 4111/4885CCR1 3762/4885 |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | TGFBR1 4281/4885IRAK4 4111/4885CCR1 3762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.